Acyclovir Prophylaxis of Herpes-Simplex-Virus Infections
- 9 July 1981
- journal article
- research article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 305 (2), 63-67
- https://doi.org/10.1056/nejm198107093050202
Abstract
We conducted a double-blind, placebo-controlled study of acyclovir prophylaxis against infection with herpes simplex virus (HSV) in 20 seropositive recipients of bone-marrow transplants. Acyclovir or placebo was administered for 18 days, starting three days before transplantation.This publication has 22 references indexed in Scilit:
- Infection with Herpes Simplex Virus and Cell-Mediated Immunity after Marrow TransplantThe Journal of Infectious Diseases, 1980
- Effect of Acyclovir on Recurrence of Herpes Simplex Skin Lesions in MiceJournal of General Virology, 1980
- PARENTERAL ACYCLOVIR THERAPY FOR HERPESVIRUS INFECTIONS IN MANThe Lancet, 1979
- Acyclovir in Oral and Ganglionic Herpes Simplex Virus InfectionsThe Journal of Infectious Diseases, 1979
- Latent Herpes Simplex Virus Infections in Sensory Ganglia of Hairless Mice Prevented by AcycloguanosineAntimicrobial Agents and Chemotherapy, 1979
- Growth Inhibition by Acycloguanosine of Herpesviruses Isolated from Human InfectionsAntimicrobial Agents and Chemotherapy, 1979
- Effect of Acycloguanosine Treatment on Acute and Latent Herpes Simplex Infections in MiceAntimicrobial Agents and Chemotherapy, 1979
- Acycloguanosine Treatment of Herpesvirus Infections in Footpads and Nervous Tissue of Normal and Immunosuppressed MiceIntervirology, 1979
- 9-(2-Hydroxyethoxymethyl)guanine activity against viruses of the herpes groupNature, 1978
- Selectivity of action of an antiherpetic agent, 9-(2-hydroxyethoxymethyl)guanineProceedings of the National Academy of Sciences, 1977